SCHEMBL19080930

SCHEMBL19080930

CC1(C)c2ccc(-c3ccc(-c4c5ccccc5c(-c5cccc6ccccc56)c5ccccc45)c4ccccc34)cc2-c2cc3c(cc21)oc1c2ccccc2ccc31

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 2/20 0.33
ARSA P15289 1/20 0.33
CDC25A P30304 1/20 0.33
CDC25C P30307 1/20 0.33
ALOX5 P09917 1/20 0.33
CYP1A1 P04798 5/20 0.32
CYP1B1 Q16678 5/20 0.32
KMT2A Q03164 1/20 0.32
PSD A5PKW4 1/20 0.32
CYP1A2 P05177 4/20 0.32
ABCB1 P08183 1/20 0.32
ABCC1 P33527 1/20 0.32
ABCG2 Q9UNQ0 1/20 0.32
CHRNA1 P02708 1/20 0.31
CHRNG P07510 1/20 0.31
CHRNB1 P11230 1/20 0.31
CHRNB2 P17787 1/20 0.31
SLC6A2 P23975 1/20 0.31
CHRNB4 P30926 1/20 0.31
SLC6A4 P31645 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19080925 0.97 PRKDC (0.34) PRKDCARSACDC25ACDC25CALOX5
SCHEMBL19080822 0.93 PRKDC (0.33) PRKDCCYP1A1CYP1B1KMT2APSD
SCHEMBL19080892 0.93 CYP1A1 (0.35) PRKDCARSACDC25ACDC25CCYP1A1
SCHEMBL19080741 0.91 CYP1A1 (0.35) PRKDCARSACDC25ACDC25CCYP1A1
SCHEMBL19080821 0.90 PRKDC (0.33) PRKDCCYP1A1CYP1B1KMT2APSD
SCHEMBL19080846 0.88 CYP1A1 (0.32) PRKDCARSACDC25ACDC25CCYP1A1
SCHEMBL19109412 0.88 ALOX5 (0.38) PRKDCALOX5KMT2ACHRNA1CHRNG
SCHEMBL19081053 0.87 ALOX5 (0.34) PRKDCALOX5
SCHEMBL19081749 0.87 PRKDC (0.33) PRKDCARSACDC25ACDC25CABCB1
SCHEMBL19080928 0.87 ALOX5 (0.33) PRKDCALOX5KMT2APSDCHRNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 PRKDC 4719/4885ARSA 4543/4885CDC25A 71/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 PRKDC 4719/4885ARSA 4543/4885CDC25A 71/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.